Certified by Founder Lodge
Sands Capital
United States - Arlington, VA
INVESTOR
1 Disclosed Funding Rounds $223,000,000
20 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines analytical rigor and creative thinking to seek to identify high-quality growth
| Company | Date | Round | Raised |
|---|---|---|---|
 Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
 Cleerly |
July, 25 ,2022 | Series C | $223,000,000 |
 HAWK:AI |
January, 27 ,2023 | Series B | $17,000,000 |
 Alamar Biosciences, Inc. |
February, 27 ,2024 | Series C | $128,000,000 |
 Papercup |
June, 09 ,2022 | Series A | $20,000,000 |
 Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
 Selux Diagnostics, Inc |
March, 01 ,2022 | Series C | $50,000,000 |
 HUNGRY |
June, 26 ,2023 | Series C | $10,000,000 |
 Chronicle Studios |
June, 25 ,2025 | Seed | $11,000,000 |
 OneTrust |
July, 25 ,2023 | Unknown | $150,000,000 |
 RevEng.AI |
July, 01 ,2025 | Seed | $4,150,000 |
 Beta Bionics |
September, 04 ,2023 | Series D | $100,000,000 |
 SafeRide Health |
October, 06 ,2023 | Series C | |
 Cytovale |
November, 16 ,2023 | Series C | $84,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Alamar Biosciences, Inc. |
February, 27 ,2024 | Series C | $128,000,000 |
| Credo AI |
July, 31 ,2024 | Unknown | $21,000,000 |
| Chronicle Studios |
June, 25 ,2025 | Seed | $11,000,000 |
| RevEng.AI |
July, 01 ,2025 | Seed | $4,150,000 |
 Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
